Ad
related to: moderna
Search results
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 14 hours agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 11 hours agoOn Monday, RBC (TSX:RY) Capital Markets adjusted its outlook on Moderna (NASDAQ:MRNA) shares,...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 3 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 10 hours ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 10 hours agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 3 hours agoInsights from TIME, The Washington Post, MIT Technology Review The News Pharmaceutical giants ...
US FDA approves Moderna’s RSV vaccine, its second marketed product
WHTC 1450 Holland· 3 days agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 18 hours agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga· 6 hours agoMonday, Moderna Inc MRNA and Merck & Co Inc MRK announced the first presentation of results from a planned analysis from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study. The ...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 3 days agoModerna confirmed it's in discussions with the U.S. government to move forward with its bird flu...